Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Nov 25, 2014 · 10-Q · 56 days after period end · 0001171843-14-005683
| Metric | Q3 2014 | Q3 2013 |
|---|---|---|
| Revenue | $2.95M | — |
| Net Income | -$5.18M | -$2.10M |
| EPS Diluted | -$31.00 | -$15.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 25, 2014 · 56 d after period end
